Sharon Sheehan

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Scott A. Prentice, Tom Michael Mitchell, Deborah A. Gilliam, 2017 .

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults

P. Moss, B. Landry, H. McShane, 2015, PloS one.

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial

H. McShane, Joel Meyer, Sharon Sheehan, 2014, The Lancet. Infectious diseases.

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Scott A. Prentice, Tom Michael Mitchell, Deborah A. Gilliam, 2018, Lancet.